KBP Biosciences
Business Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
116 Village Blvd Ste 210, Princeton, New...Website
www.kbpbiosciences.comRevenue
$24.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About KBP Biosciences
KBP Biosciences is a leading biotechnology research and development organization focused on delivering innovative therapies for unmet medical needs. The company leverages its integrated discovery and development platform to advance its strong pipeline of clinical and preclinical programs targeting hypertension, cardiorenal, and infectious diseases. Their aim is to provide novel solutions that make a significant impact in global health. KBP's intended clients include healthcare providers, patients suffering from these diseases, and stakeholders in the pharmaceutical community.Explore more
KBP Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KBP Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on KBP Biosciences recently announced quarterly report
KBP Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if KBP Biosciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at KBP Biosciences
Click to see if KBP Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once KBP Biosciences has new funding data
Product Launch: Get notified when KBP Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if KBP Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined KBP Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to KBP Biosciences
Compare insights from companies similar to KBP Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
$26.1M
11-50
Private
-
2002
HP
Hans-Peter PflegerVice President, Commercial Operations & Strategic Marketing
Company Profile Activity
Activity Insights
KBP Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KBP Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KBP Biosciences.
KBP Biosciences financials insights
Gather financial insights about KBP Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$76M
KBP Biosciences Tech Stack
A closer look at the technologies used by KBP Biosciences
Most Recent Scoops
Open Position
Left Company
Executive Move
New Hire
Executive Move
Management Move
Executive Move
Executive Moves
Management Move
Executive Move
Executive Moves
KBP Biosciences News & Media
KBP's Contest of Injunction Obtained by Novo Nordisk Continues in Arbitration
SINGAPORE, Aug. 13, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang"), in support of arbitration proceedings respectively commenced by the Company and by Novo Nordisk A/S ("Novo Nordisk"). Following the Court's judgment today, the validity of the injunction applicKBP to Contest Injunction Obtained by Novo Nordisk
SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a recent decision by the Singapore International Commercial Court ("SICC"), which granted an injunction sought by Novo Nordisk A/S ("Novo Nordisk") against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang") on February 14, 2025. The SICC decision was issued on an ex parte basis without the knowledge or participation of the Company and Dr. Huang. NovoNovo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up to 1.3 billion US dollars.Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
PRINCETON, N.J., April 17, 2023 /PRNewswire/ -- EMJ Nephrology interviewed two World-renowned experts in nephrology and cardiology, George Bakris and Faiez Zannad, regarding the challenges of treating uncontrolled hypertension (uHTN) in patients with advanced chronic kidney disease (CKD),...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding KBP Biosciences
Sign Up For FreeTo access detailed company insights
KBP Biosciences is a leading biotechnology research and development organization focused on delivering innovative therapies for unmet medical needs. The company leverages its integrated discovery and development platform to advance its strong pipeline of clinical and preclinical programs targeting hypertension, cardiorenal, and infectious diseases.... Read More
